1-3 of 3
Authors: Mark Remke
Sort by
Journal Article
MBCL-21. GERMLINE ELONGATOR MUTATIONS IN SONIC HEDGEHOG MEDULLOBLASTOMA Open Access
Giles W Robinson and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii392–iii393, https://doi.org/10.1093/neuonc/noaa222.497
Published: 04 December 2020
Journal Article
IMMU-18. FAVORABLE OUTCOME IN REPLICATION REPAIR DEFICIENT HYPERMUTANT BRAIN TUMORS TO IMMUNE CHECKPOINT INHIBITION: AN INTERNATIONAL RRD CONSORTIUM REGISTRY STUDY Open Access
Eric Bouffet and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii363, https://doi.org/10.1093/neuonc/noaa222.374
Published: 04 December 2020
Journal Article
IMMU-20. IMMUNE AND TUMOR BIOMARKERS OF OUTCOME IN REPLICATION REPAIR DEFICIENT BRAIN TUMORS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: UPDATES FROM THE INTERNATIONAL REPLICATION REPAIR DEFICIENCY CONSORTIUM Free
Eric Bouffet and others
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Pages ii96–ii97, https://doi.org/10.1093/neuonc/noz036.139
Published: 23 April 2019
Advertisement
Advertisement